Cellmid, Key European Patent for Anti-Midkine Antibodies Granted Finance News Network SYDNEY, Tuesday, 8 October 2013: Cellmid Limited (ASX:CDY) advises that the European Patent Office has granted one of Cellmid's most important antibody patents, application EP07828015.3 (patent '15.3) entitled "Antibody recognising Cdomain of ... |